Although I am as desperate for a cure as anyone else on this forum - I'm not even sure Shiseido has actually stated that they'll have a cure in 2018. The article that everyone quotes: (
http://en.rocketnews24.com/2015/07/0...arket-by-2018/) doesn't actually have any direct quotations from Shiseido. It's written by two people that collectively refer to themselves as Master Blaster and, for all we know, Master Blaster heard that Shiseido was going to be starting hair loss trials later on this year, could potentially bring the treatment to market in 2018 - and decided to hail this as a cure.
Does anyone have a direct quotation from Shiseido saying that they'll have a cure in 2018? To my knowledge, Shiseido didn't even react to this article.
If a cure comes out in Japan in 2018, make no mistake about it - I'll be flying there (however many times it takes) and will pay (whatever the price) for however many injections are necessary to give me back a full head of hair. Hair loss f.cking sucks...
I would love to believe that Replicel is going to be the cure - but honestly - I think that's a huge stretch based on their Phase 1 data:
http://replicel.com/wp-content/uploa...s-Nov-2012.pdf
The average increase in density at injected sites was 6.1%. So in a given area - if a normal density is say - 200 hairs - and you have 100 hairs - then replicel is giving you 6 more hairs. That's pretty underwhelming. And I know Phase 1 was for safety and they'll be increasing the dose and number of injections in Phase 2 - and they also may have improved their technology in the intervening years - but it's hard to believe that's going to be enough for the cure... I mean - 3 of 16 individuals lost hair with Replicel - so if increasing the dose is going to amplify results - does that mean these 3 people will just get worse??
I'm fairly certain Replicel knows they're not the cure. After the article from Master Blaster, they went out of their way to effectively say - "yeah - um - we're not guaranteeing any of this... in theory it's definitely possible, but...". Right now all Replicel is claiming is that they are optimistic that their current treatment will be an effective form of maintenance - but even that claim - aside from it theoretically making sense - has NO human (? any) data to back it up.
With regards to differences between Replicel's current treatment and the treatment that Shiseido plans to offer in 2018 - again - I don't think anyone actually knows for certain.
As everyone knows, Replicel released two videos in May that featured Shiseido discussing hair loss research. The first video discussed Replicel's RCH-01 technology. At the end of the first video, they explicitly state that the second video relates to ongoing research involving iPS cells for hair regeneration - which is SEPARATE from Replicel's technology.
https://www.youtube.com/watch?v=oKRwlNuDMU0
The second video features Takashi Tsuji discussing his research, followed by Manabu Ohyama talking about iPS cells. It appears that Ohyama works with Shiseido, but I think Tsuji still works at Tokyo University.
https://www.youtube.com/watch?v=-p0Hvrx093I
Neither Tsuji's work nor Ohyama's work is ready for human trials. So it's hard to believe that Shiseido will be able to incorporate their technology into a product that will be ready for 2018.
Could we have a cure by 2020? Anything is possible - the JAK inhibitors for alopecia areata seemingly came out of nowhere and changed the game.
Could the same happen for us? Maybe - let's f.cking hope so...
Bookmarks